China has developed rapidly in the pharmaceutical industry in
the past few years and has become one of the largest and most
active pharmaceutical markets in the world. To further encourage
innovation in drug development, China has initiated a series of
regulatory and patent reforms in the pharmaceutical industry in
recent years, including the implementation of patent term extension
(PTE).
Background
The pharmaceutical industry is highly dependent on patent
protection due to the high cost, long cycle and high risk of
researching and developing new drugs. Without patent protection, it
would be difficult for innovative drug companies to recover their
research and development costs and achieve reasonable profits,
thereby negatively affecting their enthusiasm for research and
development of new drugs. However, drug marketing requires strict
approval by the drug regulatory authorities, including a series of
studies like non-clinical safety evaluation and clinical